Recombinant Human LMP7 Protein，His

LMP7, a member of the immunoproteasome family, plays a crucial role in antigen processing and presentation in immune responses. Unlike the constitutive proteasome, the immunoproteasome is activated during immune-related stress and inflammation, enhancing the production of peptide fragments that bind to major histocompatibility complex (MHC) class I molecules. This process is vital for the effective activation of CD8+ T cells, which are critical in eliminating infected or malignant cells. Research into LMP7 recombinant protein has gained momentum due to its potential implications in immunotherapy and vaccine development. Understanding its structure and function can aid in designing strategies to boost immune responses against tumors and chronic infections. Furthermore, LMP7 is being investigated for its role in various autoimmune diseases, where an imbalance in proteasome function may lead to aberrant immune activity. The recombinant production of LMP7 allows for detailed biochemical studies and the exploration of its interactions with other proteins, providing insights into its function in the immune system. As a target for therapeutic intervention, modulating LMP7 activity could lead to innovative treatments that enhance immunity or mitigate autoimmune disorders. Thus, the research on LMP7 recombinant protein not only contributes to fundamental immunology but also holds promise for advancing clinical applications in immunotherapy and disease management.